ART and Ferndale Labs Enter into Commercial Deal in August 2015

As of August 2015, ART has entered into a commercial deal with Ferndale labs which will provide a 5% royalty stream to ART starting in 2016. Mastisol® Plus will compete in the $100M North American surgical adhesive marketplace until 2033.